Last reviewed · How we verify

NCT07418346

Evaluating Pain and Functional Outcomes of Active Release Technique Versus Strain-counter- Stain in Chronic Low Back Pain .A Randomized Clinical Trial

Completed NA Last updated 18 February 2026
What this trial tests

NA trial testing SCS in Low Back Pain in 40 participants. Completed in 15 August 2025.

Timeline
5 May 2025
Primary endpoint
5 August 2025
15 August 2025

Quick facts

Lead sponsorIbadat International University, Islamabad
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date5 May 2025
Primary completion5 August 2025
Estimated completion15 August 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Ibadat International University, Islamabad

Who can join

Adults 30 to 45, male only, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

clinical trial aims to compare the effects of Active Release Technique (ART) and Strain-Counter-Strain (SCS) on pain reduction and functional improvement in male patients aged 30-45 years with chronic low back pain (CLBP) persisting for at least 3-4 months. CLBP is a widespread and debilitating condition with significant impact on quality of life, healthcare costs, and work productivity. ART focuses on releasing myofascial adhesions and alleviating trigger points through manual pressure and movement, while SCS is a passive positional technique designed to reduce neuromuscular tension and restore range of motion. A total of 40 participants will be randomly allocated into two equal groups (ART group and SCS group). Both groups will receive standardized baseline treatment including a hot pack and interferential current therapy, followed by their respective intervention protocols for 12 sessions over 4 weeks. Pain intensity will be measured using the Visual Analogue Scale (VAS), functional disability using the Quebec Back Pain Disability Scale (QBPDS), and functional limitation using the Oswestry Disability Index (ODI). Data will be analyzed using SPSS v25, applying paired and independent t-tests or their non-parametric equivalents, with a significance level of p \< 0.05. The study is expected to provide evidence-based insight into which intervention is more effective in improving pain and functional outcomes in CLBP. The findings may help guide clinical decision-making, contribute to treatment guidelines, and support cost-effective, patient-centered management approaches.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of SCS

Trials testing the same drug.

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Ibadat International University, Islamabad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07418346.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing